The 12 Panel Dip Drug Test CLIA Waived from Ovus Medical is engineered for reliable urine drug screening in regulated and non-regulated settings. This FDA Approved test meets CLIA waiver requirements, allowing it to be used in clinical environments without specialized laboratory certification. The dip card format supports fast deployment, minimal sample handling, and straightforward result interpretation.
Designed for high-volume and routine testing, the 12 Panel Dip Drug Test is commonly used by employers, healthcare providers, treatment facilities, and compliance programs that require dependable screening tools. The test delivers clear visual results that are easy to read, reducing user error and improving workflow efficiency.
Manufactured under strict quality control standards, each 12 Panel Dip Drug Test offers consistent sensitivity and performance. The compact design makes storage and distribution simple, while the extended shelf life supports inventory planning for bulk buyers. Ovus Medical supplies this product with professional packaging, dependable availability, and fast shipping.
Key Benefits
-
✔ CLIA Waived urine screening device
-
✔ FDA Approved for professional reliability
-
✔ Fast dip test results with minimal steps
-
✔ No laboratory equipment required
-
✔ Ideal for workplace, clinical, and monitoring use
-
✔ Bulk pricing available through Ovus Medical
-
✔ Trusted nationwide for consistent performance
When accuracy, speed, and regulatory compliance matter, the 12 Panel Dip Drug Test from Ovus Medical delivers a dependable solution designed to meet modern screening demands.




Negative: Two colored bands appear on the membrane. One band appears in the control regions (C), and another in the test region(T).













